Anthos Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Anthos Therapeutics's estimated annual revenue is currently $5.9M per year.
- Anthos Therapeutics's estimated revenue per employee is $98,167
Employee Data
- Anthos Therapeutics has 60 Employees.
- Anthos Therapeutics grew their employee count by 76% last year.
Anthos Therapeutics's People
| Name | Title | Email/Phone |
|---|
Anthos Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | N/A | 11 | 10% | N/A | N/A |
#10 | $5.4M | 35 | 3% | N/A | N/A |
What Is Anthos Therapeutics?
Anthos Therapeutics is a clinical-stage biopharmaceutical company developing and commercializing innovative therapies for high-risk cardiovascular patients. Anthos is a formation of Blackstone (NYSE: BX) Life Sciences and Novartis AG (NYSE: NVS), one of the worlds’ leading pharmaceutical companies. The company is led by a world-class executive team highly experienced in the successful development of therapies for cardiovascular disease.
keywords:N/A
N/A
Total Funding
60
Number of Employees
$5.9M
Revenue (est)
76%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $9.3M | 60 | -19% | N/A |
#2 | $15M | 60 | 11% | N/A |
#3 | $17.6M | 60 | -3% | N/A |
#4 | $14.1M | 60 | 11% | N/A |
#5 | $14.9M | 60 | 22% | N/A |